Skip to main content

Factors associated with medication adherence of hypertensive patients in the Philippines: a systematic review



Diseases of the heart and vascular system are the leading cause of mortality in the Philippines. Hypertension, the most important modifiable risk factor, has a prevalence rate of 28% and a control rate of 20%. Despite the proven efficacy of pharmacologic treatment, medication adherence is reported to be as low as 66%. While there are publications that reported factors that affect adherence in Filipinos, there are no existing research that evaluated them systematically. This review is conducted to present and synthesize findings of published literatures.


Databases—PubMed, Scopus, Wiley Online library, Science Direct, JSTOR, Web of Science, SAGE journals, and Cochrane—were used to search for articles published from 2000 to 2020 that studied medication adherence in adult Filipino hypertensive population. Out of the initial 1514 articles, 15 articles met the criteria and were included in the analysis. The evidence from the included studies was summarized and discussed in a narrative review using the World Health Organization framework for adherence to long-term therapies as the framework.


The factors that were positively associated with adherence were health care system-related factors: good patient-health provider relationship, accessibility of health services, use of specialty clinics and programs for hypertension, and health insurance. The factors found to be negatively associated with adherence are (1) social economic factors: younger age, single civil status, low educational attainment, and unemployment; (2) patient-related factors: low in health literacy and awareness, knowledge on hypertension, attitude towards hypertension, self-efficacy, and social support; (3) therapy-related factors: inconsistent drug regimen schedule, use of Thiazide and complementary and alternative medicines; (4) condition-related factors: low illness perception, and absence of comorbidities.


Findings should be interpreted with caution because of methodological limitations. Despite this, given that health systems related factors are modifiable, they can be the focus of interventions and future researches to increase medication adherence. Clinicians may also want to screen their Filipino hypertensive patients for factors that are associated to low adherence in order to provide a tailored advice. Longitudinal research studies with heterogeneous samples of hypertensive Filipinos are imperative so that targeted interventions can be developed for the population.


Six of the ten leading cause of death in the Philippines are non-communicable in etiology, the leading cause being cardiovascular diseases [1]. A systematic review by Kearney et al. PM Kearney, M Whelton, K Reynolds, P Muntner, PK Whelton and J He [2] found that hypertension is a the most important modifiable risk factor for stroke and myocardial infarction that applies to both developed and developing countries. A prospective, multi-staged, stratified nationwide survey on hypertension was conducted in the Philippines found that the prevalence of hypertension is 28% or approximately 29 million citizens, and it is projected to increase over time [3,4,5]. According to Musini et al. VM Musini, AM Tejani, K Bassett and JM Wright [6], treating healthy persons (60 years or older) with moderate to severe systolic and/or diastolic hypertension with antihypertensive drug, reduces all-cause mortality and cardiovascular morbidity and mortality. Despite the proven efficacy of antihypertensive drugs in controlling blood pressure, patient adherence in clinical practice is reported to be as low as 20 to 50% and therefore it can be presumed that many patients, experience difficulty in following long-term treatment recommendations [7].

Adherence, as defined in chronic disorders context by the World Health Organization (WHO) [8] is “the extent to which a person’s behavior with respect to taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a healthcare provider”. High adherence is defined objectively as medication possession ratio of 80 to 100%. Historically, high adherence to hypertensive medications is associated with higher blood pressure control [9]. In 2007, Philippine Heart Association-Council on Hypertension Report on Survey of Hypertension showed treatment rates for hypertension is at 65%, however, of those receiving treatment the adherence rate is at 66% resulting to a hypertension control rates of only 20% [10]. This is consistent to the findings of de Guzman et al. [11] where they found out that the elderly Filipino patients have low adherence at only 41.54%.

While it is easy to assume that perhaps medicine access is the main barrier to adherence, there are findings that suggest that even Filipino immigrants in developed countries are also non adherent to hypertensive medication therapy, when compared to other Asian American counterparts despite the availability of medications [12,13,14,15,16]. Thus raising the question if there culturally or uniquely Filipino characteristics or factors that contribute to phenomenon of non-adherence beyond barriers of access. Moreover, the Philippine government in the last 10 years have medicine access programs to respond to the persistently high out of pocket spending and barriers to access to essential drugs [17,18,19]. While there are weaknesses in the implementation of these program it is still worth exploring if there are other factor beyond medicine access that contribute to medication adherence [19].

The purpose of this article was to critically review the literature on factors associated with medication adherence in hypertensive Filipinos. No such systematic review appears to have been previously conducted. The review may be used to recommend focus of future researches and propose interventions to improve it in hypertensive Filipino patients.

Main text

Data sources and search strategy

The search strategy was run on eight databases: PubMed, Scopus, Wiley Online library, Science Direct, JSTOR, Web of Science, SAGE journals, Cochrane library between the year 2000 to 2020. A facet analysis broke the review question into its component parts population (Filipino), intervention (for hypertension and anti-hypertensive) and outcome (medication adherence). Index terms such as ‘hypertension’ and ‘medication adherence’ were explored and all sub-headings were included. The resulting search term is ((((((“patient compliance”) OR “patient adherence”) OR “medication compliance”) OR “medication adherence”)) AND ((Antihypertensive) OR Hypertension)) AND ((Philippines) OR Filipino). Subsequently, the reference list of included studies were scrutinized to identify additional relevant studies. Corresponding authors were searched and contacted to include these literatures in the review as well.

Study selection

Study samples included in the review were individuals aged 18 years and above of Filipino ethnicity, with hypertension and receiving antihypertensive treatment from primary care, outpatient or community setting. The outcomes considered in the review was medication adherence that is measured using objective measures or validated subjective (self-reported) instruments, summarized in Table 1 [14, 16, 20,21,22,23,24,25,26,27,28]. Review articles, conference presentations and discussion papers were excluded. The process of selecting these studies are illustrated in Fig. 1 flow diagram of the search strategy based on PRISMA [29].

Table 1 Outcome measures for medication adherence
Fig. 1

Flow diagram of the search strategy based on PRISMA

Data extraction and screening

All retrieved articles were organized and screened using a Microsoft Excel spread sheet and EndNote management software. After removing duplicates, articles’ titles and abstracts were assessed for eligibility. Then, the full-text articles were screened and data of the eligible articles were extracted into a standardized data extraction table. Extraction of the data was based on the following categories: research design, objective, study setting, sampling technique, sample size, eligibility criteria, measure of medication adherence, independent variables tested, medication adherence result, key findings and any statistical information (odds ratios, 95% confidence interval, P-value, correlation coefficients). Quality of the studies was evaluated and reported using the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) for observational studies, Consolidated Standards of Reporting Trials (CONSORT) 2010 for parallel group randomized trials and the Joanna Briggs Institute Checklist for Quasi-Experimental Studies.

Data analysis

A meta-analysis of the findings was not possible due to the heterogeneity of important aspects of the methodology of the selected studies including sampling procedure, population ages, study settings, study design and measurement procedure of medication adherence. Descriptive analysis of studies examining similar variables and any association observed were considered to offer a simple indication of the level of evidence. Summary ranges of quantitative proportions and measures relating to prevalence and factors associated with medication adherence were compiled and presented on Table 1 [14, 16, 20,21,22,23,24,25,26,27,28] and Table 2 [11, 14,15,16, 21, 23, 25,26,27, 31, 34,35,36,37,38] The evidence from the studies was synthesized and presented in a narrative review following the WHO’s report on adherence as the framework of the review. In this framework, there are five interacting dimensions for medication adherence: (1) social/economic factors, (2) patient-related factors, (3) health team and system-related factors, (4) therapy-related factors, and (5) condition-related factors [8].

Table 2 Description of the studies


A total of 1472 citations from the databases were identified. After elimination of duplicate records and abstract screening, 93 articles were full-text reviewed. The reference list of the selected literatures was then scrutinized that resulted in the inclusion of 42 articles for further screening. The final number of articles included in this systematic review is 15: one randomized controlled trial [38], three quasi-experimental [21, 26, 36], three observational retrospective analysis [14,15,16], and eight observational cross-sectional study [11, 23, 25, 27, 31, 34, 35, 37]. The description of the included studies is summarized in Table 2. The cumulative number of study participants is 21,668 with age of ranging between ages 18 to 75 years old.

Medication adherence

Of the 15 studies on Table 3 [11, 14,15,16, 21, 23, 25,26,27, 31, 34,35,36,37,38] only two studies [23, 27] reported a baseline medication adherence to be high, however in both researches, a subjective or self-reported adherence method is used for measurement. The rest of the studies reported low adherence, four [14,15,16, 34] of them utilize objective measure for medication adherence.

Table 3 Summary of findings

Social/economic factors

The systematic review identified eight studies in which social/economic factors from the WHO adherence model was examined. Eight studies examined the association between age and medication adherence; Five of the studies determined that there is a significant negative association between younger age and adherence rates [14,15,16, 25, 26]. Three of the five use retrospective analysis and objective measures of medication adherence [14,15,16]. In two of the studies the age group below 40 years old is twice less likely to be adherent when compared to 40 to 64 years old [16, 26]. It should be noted however that three studies that use cross-sectional study design did not find an association between age and medication adherence [21, 23, 27].

Four studies examined the association between gender and medication adherence; two of them determined that there is a significant association while the other two stated that they found none. The conclusions of both studies are inconsistent, in terms of which sex (male or female) has lower adherence [14, 21]. Overall, the result is in inconclusive.

Only one study examined the association of civil status, they determined that in sample of 56 participants married female participants has higher adherence [21]. Two studies examined if the educational attainment impacts the medication adherence; Taira et al. [15] determined that adherence improved with increased educational attainment, however in both Coyoca et al. [21] and Palileo-Villanueva et al. [27] no association was found. Coyoca et al. [21] found an association between work and adherence where working patients has higher adherence.

Patient-related factors

Patient-related factors are the knowledge, attitudes, beliefs, and perceptions of hypertensive patients [8]. There are six literatures that examined patient-related factors. Patient’s health literacy has positive relationship but not statistically significant in the study conducted by Mamangon et al. [26]. Disease awareness on the other hand is statistically significant in the study of Coyoca et al. [21] where they related this to the coping mechanism to stress of the participants. In two literatures, knowledge is directly associated with medication adherence [25, 35]. For attitude, three studies concluded that positive attitude lead to higher adherence [11, 25, 35].

Result of studies on self-efficacy is mixed, one of the studies did not find an association, but in two of them concluded that higher patient’s perceived self-efficacy is associated with higher adherence [11, 25, 35]. In the case of social support, three studies found a direct relationship between social support system and higher adherence [21, 25, 27]. Specifically, in the study of Palileo-Villanueva et al. [27], they specifically found that patients that were being supported by their children financially were twice more likely to be adherent.

Health team and system-related factors

Healthcare team and system-related factors include patient provider relationship and logistical barriers to healthcare [8]. Accessibility to health services and insurance whether locally or abroad showed positive relationship with adherence. Locally, Coyoca et al. [21] and Dror et al. [34], statistically proven the link where insured persons reported better drug compliance among chronically ill. Consistent findings were observed in Filipinos residing abroad, they determined that copayment level, independent of other determinants, was found to be a strong predictor of compliance with antihypertensive medications specifically when offered by the patient’s preferred organization. In addition, greater compliance was seen among patients filing pharmacy claims for drugs that required lower copayments. They also found an inverse relationship with compliance to medications in the most expensive tiers [16].

Four literatures examined the effect of patient and health care provider relationship, Coyoca et al. [21] determined that there is a positive relationship between good relationship and adherence, this is also consistent with the findings of Mamangon et al. [21, 26]. In the de Guzman et al. [11]‘s study, an interesting finding is that higher trust with physician resulted to higher adherence, but curiously if the patient has high satisfaction with the doctor consultation the adherence tend to be low. In Taira et al. [15]‘s study, a study conducted abroad, found out that adherence was higher if patients are consulting with primary care doctors over specialist. Filipino patients also tend to have lower adherence with a female and Filipino physicians.

In three studies, consultation in specialty continuity clinics for hypertension showed positive relationship with adherence whether it is public or privately managed institution [21, 25, 27]. The same positive relationship is observed in the four community-based health programs researched, regardless whether they are a short term (2-h lecture) or long-term (6 months program). There is an observed increase in adherence post-intervention in these researches [31, 36,37,38].

Therapy-related factors

Therapy-related factors include the complexity of the medical regimen, duration of treatment, frequent changes in treatment, and adverse effects [8]. The findings with regards to number of medications or polypharmacy is mixed in three of the studies; de Guzman et al. [11], found that the number of medication is inversely proportional with medication adherence. But in two of the studies, it appears that the increasing number of medication led to higher adherence. In Palileo-Villanueva et al. [27], they specifically stated that the odds of being more adherent increases by 1.15 times if the patient has polypharmacy. In Juarez et al. [14], they emphasized that poly pharmacy on lipid-lowering and antidiabetic medications are statistically significantly increased adherence on antihypertensive.

Despite the two latter findings that associated polypharmacy and adherence positively it should be noted that, certainly confounders, such as multiple comorbidities, advance stage of illness, and patient’s illness representation among others may have contributed to this. In other words, the statement “odds of being more adherent increases by 1.15 times if the patient has polypharmacy” should have be more accurately reported as “patients in the advance stages of their illness with multiple medications are more adherent by 1.15 times”. In order to validate the result and to avoid hasty conclusions, it is recommended for future researchers that when studying the association of adherence and polypharmacy, instead of running a univariate analysis it would be better to use multivariate regression models in order to account for potential sources of bias from confounders. This recommendation is consistent with studies conducted in other countries where it has shown repeatedly that fewer medications improved adherence.

In Encabo et al. [23], the use of maintenance drugs that means consistent scheduling of medication had a positive relationship with adherence. An interesting findings of de Guzman et al. [11] appeared that Filipino elderly preferred no assistance in remembering medication intake whether using event-based memory or external memory based strategy. In Taira et al. [15], they suggested that adherence is highest for beta blockers and calcium channel blockers, followed by angiotensin receptor blockers and angiotensin-converting enzyme inhibitors and that adherence is lower in thiazide diuretics. This finding is somewhat consistent with Taira et al. [16], thiazide diuretics also has the lowest adherence, but in this paper best compliance observed for angiotensin receptor blockers, followed by calcium channel blockers, beta blockers, angiotensin-converting enzyme inhibitors in that order. With regards to CAM, Pablo et al. [36] found that medication adherence is higher if the patients has low attitude towards CAM.

Condition-related factors

Condition-related factors are those illness-related demands faced by the patient, such as severity of blood pressure, absence or presence of symptoms, and level of disability and/or comorbidities [8]. For the number of comorbidities, it appears that the finding for Filipinos abroad have different pattern compared to patients locally. In the finding of de Guzman et al. [11] and Mamangon et al. [26] as the number of other conditions increased, adherence also increased. But in Taira et al. [16], a study conducted abroad, lower medication compliance was seen in those patients with high morbidity.

As for the type of comorbidity, Juarez et al. [14] determined that history of either coronary artery disease or congestive heart failure was significantly associated with more years of adherence to antihypertensive medications. The result conducted abroad however, showed an opposite relationship. For Taira et al. [15], the history of heart disease has lower adherence but history of diabetes tended to be more adherent.


The result of medication adherence is consistent with the national survey reported in PRESYON2 that the adherence among those treated for hypertension is 66% [10]. The factors found that are consistently associated with adherence across the included studies were all health systems related. The factors that increase adherence are (1) accessibility of health services, (2) positive relationship with providers of health services, (3) specialty clinics and programs for hypertension, and (4) health insurance. This is comparable to the finding in the United States, where patients reporting better access to health care, satisfaction with their care and a good patient-doctor relationship were significantly more likely to be more adherent [40].

The number of studies conducted exploring reasons for non-adherence in hypertensive Filipinos is limited and majority are also cross-sectional which makes it difficult to assess causality. Further, we don’t know if the relationships are sustained over time. Despite these limitations, given that health team and system-related factors are modifiable, these can be the focus of interventions and further research to increase medication adherence.

The other four dimensions of medication adherence, have patterns of association as well, but are not consistent in all included studies. The factors that are associated to poor adherence are younger age, single in civil status, low educational attainment, unemployment, low health literacy and awareness, low knowledge on hypertension, negative attitude towards hypertension, low self-efficacy, low social support, inconsistent drug regimen schedule, taking Thiazide diuretics, taking CAMs, low illness perception, and no comorbidities as seen in Fig. 2. Factors that are associated with Adherence in Filipinos These findings, must be interpreted with caution because of the small number of studies and the fact that most were cross-sectional as well. Healthcare providers may still consider screening for these issues when dealing with their hypertensive patients.

Fig. 2

Factors that are associated with Adherence in Filipinos

This review revealed that more researches are needed to determine which factors influence antihypertensive medication adherence in Filipinos. Several concerns were identified after this systematic review, first concern regarding these studies is that most of the studies were based on homogeneous samples of hypertensive Filipinos, often they are even collected within the same locale or they are recruited from the same organization or health insurance providers. This will therefore limit generalizability. Another concern in interpreting the results of this review is that most of the studies measured medication adherence using subjective methods or by self-report, and there are inherent biases when using this tool. Consistent objective measurements of adherence are lacking and need to be incorporated as an outcome for future studies when exploring factors associated with medication adherence. The third concern is related to research design, since adherence is a multidimensional and dynamic process, it cannot be assumed that medication adherence and factors associated with medication adherence are stable over time. Most of the studies exploring medication adherence were observational and cross-sectional. There is a need for more longitudinal analyses of factors associated with medication adherence so that we can determine if an important factor remains associated with adherence at different time periods across a patient’s hypertensive diagnosis. Finally, there are other factors and interventions for enhancing medication adherence in hypertension like unit dose dispensing, combination pills, use of technology for dosing reminders, and blood pressure monitoring that have not been examined for their associations to medication adherence in Filipinos.


Because of the limited number and methodological limitations of included studies exploring the factors associated with medication adherence in hypertensive Filipino patients, no definitive conclusions could be made about associations. Despite this, given that health systems related factors are modifiable, they can be the focus of interventions and future researches to increase medication adherence. Review suggests that continued support and enhanced government access programs and specialty clinics for Filipino hypertensive patients is crucial to achieving better adherence rates.

In addition, clinicians must also strive to develop positive relationships with their patients and when necessary, screen for the factors related to non-adherence and adjust counselling techniques accordingly. For future researchers, more information is needed to determine the factors associated with antihypertensive medication adherence for Filipinos. Effort must be done to continue finding them through longitudinal studies that preferably use with objective instruments to measures adherence. These researches is needed so that targeted interventions for medication adherence can be further developed that will ultimately improve mortality rates among Filipino patients with hypertension.

Availability of data and materials

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.



Adherence Self-Report Questionnaire


Complementary and alternative medicines


Hill-Bone High Blood Pressure Compliance Scale


Medical Outcomes Study Specific Adherence Scale


Medication Adherence Questionnaire


Morisky Medication Adherence Scale


Medication Possession Ratio


Proportion of days covered


Self-structured questionnaires (ten items)


World Health Organization


  1. 1.

    Department of Health, Republic of the Philippines. What are the leading causes of mortality in the Philippines? 2020. Accessed 13 July 2021.

  2. 2.

    Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23.

    Article  PubMed  Google Scholar 

  3. 3.

    The Philippine health system at a glance. 2016. .

  4. 4.

    Paje R. Investment in non-communicable diseases prevention and control will save lives and contribute to the Philippines saving up to 4.8% of annual GDP. 2019. .

  5. 5.

    Mobula LM, Fisher ML, Lau N, Estelle A, Wood T, Plyler W. Prevalence of hypertension among patients attending mobile medical clinics in the Philippines after Typhoon Haiyan. PLoS Curr. 2016;8:ecurrents.dis.5aaeb105e840c72370e8e688835882ce.

    PubMed  PubMed Central  Google Scholar 

  6. 6.

    Musini VM, Tejani AM, Bassett K, Wright JM. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev. 2009;4:CD000028.

    Google Scholar 

  7. 7.

    Lehane E, McCarthy G. An examination of the intentional and unintentional aspects of medication non-adherence in patients diagnosed with hypertension. J Clin Nurs. 2007;16(4):698–706.

    Article  PubMed  Google Scholar 

  8. 8.

    World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.

    Google Scholar 

  9. 9.

    Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006;12(3):239–45.

    Article  PubMed  Google Scholar 

  10. 10.

    Sison J, Arceo LP, Trinidad E, Bautista AJ, Buan E, Chua P, et al. Philippine heart association-council on hypertension report on survey of hypertension and target organ damage (PRESYON 2-TOD*) a report on prevalence of hypertension, awareness, treatment profile and control rate. Philipp J Cardiol. 2007;35:1–9.

    Google Scholar 

  11. 11.

    de Guzman AB, Guevara KI, Guiang FJ, Gutierrez AL, Habaluyas AS, Hizon MA, et al. Developing a model of medication adherence among Filipino elderly. Educ Gerontol. 2013;39(5):298–313.

    Article  Google Scholar 

  12. 12.

    Zhao B, Jose PO, Pu J, Chung S, Ancheta IB, Fortmann SP, et al. Racial/ethnic differences in hypertension prevalence, treatment, and control for outpatients in northern California 2010-2012. Am J Hypertens. 2015;28(5):631–9.

    CAS  Article  PubMed  Google Scholar 

  13. 13.

    Ursua RA, Islam NS, Aguilar DE, Wyatt LC, Tandon SD, Abesamis-Mendoza N, et al. Predictors of hypertension among Filipino immigrants in the northeast US. J Community Health. 2013;38(5):847–55.

    Article  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Juarez DT, Tan C, Davis J, Mau M. Factors affecting sustained medication adherence and its impact on health care utilization in patients with diabetes. J Pharm Health Serv Res. 2013;4(2):89–94.

    Article  PubMed  PubMed Central  Google Scholar 

  15. 15.

    Taira DA, Wong KS, Frech-Tamas F, Chung RS. Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care. Am J Manag Care. 2006;12(11):678–83.

    PubMed  Google Scholar 

  16. 16.

    Taira DA, Gelber RP, Davis J, Gronley K, Chung RS, Seto TB. Antihypertensive adherence and drug class among Asian Pacific Americans. Ethn Health. 2007;12(3):265–81.

    Article  PubMed  Google Scholar 

  17. 17.

    Paz-Pacheco E, Jimeno C. Diabetes care in the Philippines. J ASEAN Fed Endocr Soc. 2015;30:118–23.

    Google Scholar 

  18. 18.

    Ho B. Mapping of medicine entitlement programs of the national government. Geneva: World Health Organization; 2015.

    Google Scholar 

  19. 19.

    Pinlac PA, Castillo EC, Guevarra JP, Escartin IC, Caluag ME, Granada CN, et al. The status of non-communicable disease prevention and control in the Philippines: a systematic review. Acta Medica Philippina. 2015;49:19–26.

    Article  Google Scholar 

  20. 20.

    Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs. 2000;15(3):90–6.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Coyoca GS, Chan CC, Jamero HJ, Teves GF, Tabil VG. Barriers to therapeutic regimen adherence of type II diabetes mellitus patients in Iligan City, Philippines. Proc Annu Int Conf Syiah Kuala Univ - Life Sci Eng Chapter. 2013;3:204–9.

    Google Scholar 

  22. 22.

    Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348–54.

    Article  PubMed Central  Google Scholar 

  23. 23.

    Encabo JT, Letran RA, Matias CJ, Modina SM, Payuran JA, Reyes CL, et al. Medication adherence among adult hypertensive patients in a local community in Caloocan City, Philippines. Thai J Pharm Sci. 2017;41:173–6.

    Google Scholar 

  24. 24.

    Hays RD, Kravitz RL, Mazel RM, Sherbourne CD, DiMatteo MR, Rogers WH, et al. The impact of patient adherence on health outcomes for patients with chronic disease in the medical outcomes study. J Behav Med. 1994;17(4):347–60.

    CAS  Article  PubMed  Google Scholar 

  25. 25.

    Ku GM, Kegels G. Knowledge, attitudes and perceptions of people with type 2 diabetes as related to self-management practices: results of a cross-sectional study conducted in Luzon, Philippines. Chronic Illn. 2015;11(2):93–107.

    Article  PubMed  Google Scholar 

  26. 26.

    Mamangon M, Abantao D, Bataga K, De Ocampo G, Domingo J, Lazaro C. Prevalence of medication nonadherence and level of health literacy among diagnosed hypertensives patients in a selected barangay in Manila, Philippines. In: the 6th AHLA international health literacy conference: a health literate Asia and beyond. Taichung: Asian Health Literacy Association; 2018.

    Google Scholar 

  27. 27.

    Palileo-Villanueva LM, Tan T, Mejia OJB, Briones GM Jr. T-006 factors associated with adherence to anti-hypertensive medications among patients at the general medicine outpatient clinic, Philippine general hospital. J Hypertens. 2011;29:e52.

    Article  Google Scholar 

  28. 28.

    Fairman KA, Motheral B. Evaluating medication adherence: which measure is right for your program? J Manag Care Pharm. 2000;6(6):499–506.

    Article  Google Scholar 

  29. 29.

    Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.

    Article  PubMed  PubMed Central  Google Scholar 

  30. 30.

    SCImago Journal & Country Rank. 2021. .

  31. 31.

    Calano BJ, Cacal MJ, Cal CB, Calletor KP, Guce FI, Bongar MV, et al. Effectiveness of a community-based health programme on the blood pressure control, adherence and knowledge of adults with hypertension: a PRECEDE-PROCEED model approach. J Clin Nurs. 2019;28(9-10):1879–88.

    Article  PubMed  Google Scholar 

  32. 32.

    Joanna Briggs Institute. The Joanna Briggs Institute critical appraisal tools for use in JBI systematic reviews: checklist for quasi-experimental studies (non-randomized experimental studies). 2017. Accessed 13 July 2021.

  33. 33.

    Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007;147(8):W163–94.

    Article  PubMed  Google Scholar 

  34. 34.

    Dror DM, Soriano ES, Lorenzo ME, Sarol JN Jr, Azcuna RS, Koren R. Field based evidence of enhanced healthcare utilization among persons insured by micro health insurance units in Philippines. Health Policy. 2005;73(3):263–71.

    Article  PubMed  Google Scholar 

  35. 35.

    Ea EE, Colbert A, Turk M, Dickson VV. Self-care among Filipinos in the United States who have hypertension. Appl Nurs Res. 2018;39:71–6.

    Article  PubMed  Google Scholar 

  36. 36.

    Pablo CG, Austria KA, Cortez HN, Garcia KB, Julao KG, Pulido NA, et al. Medication adherence of hypertensive and diabetic patients taking complementary and alternative medicine: an intervention study. J Soc Health. 2018;1:20–30.

    Google Scholar 

  37. 37.

    Ursua RA, Aguilar DE, Wyatt LC, Katigbak C, Islam NS, Tandon SD, et al. A community health worker intervention to improve management of hypertension among Filipino Americans in New York and New Jersey: a pilot study. Ethn Dis. 2014;24(1):67–76.

    PubMed  Google Scholar 

  38. 38.

    Ursua RA, Aguilar DE, Wyatt LC, Trinh-Shevrin C, Gamboa L, Valdellon P, et al. A community health worker intervention to improve blood pressure among Filipino Americans with hypertension: a randomized controlled trial. Prev Med Rep. 2018;11:42–8.

    Article  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134(8):663–94.

    CAS  Article  PubMed  Google Scholar 

  40. 40.

    Hyre AD, Krousel-Wood MA, Muntner P, Kawasaki L, DeSalvo KB. Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. J Clin Hypertens (Greenwich). 2007;9(3):179–86.

    Article  Google Scholar 

Download references


The research was supported by Chulalongkorn University and University of the Philippines. We are grateful to the department of social and administrative pharmacy and Department of pharmacy for their contributions to the study:


Funding for the conduct of the research is shouldered by the authors. Research grant from Chulalongkorn University and/or University of the Philippines will be requested after publication. Funding agencies plays no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.

Author information




Margarita M. Gutierrez performed, analyzed and interpreted the systematic review. Rungpetch Sakulbumrungsil performed the second independent screening and was a major contributor in writing the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Margarita M. Gutierrez.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Gutierrez, M.M., Sakulbumrungsil, R. Factors associated with medication adherence of hypertensive patients in the Philippines: a systematic review. Clin Hypertens 27, 19 (2021).

Download citation


  • Hypertension
  • Medication adherence
  • Patient compliance
  • Pharmacy
  • Philippines